Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease

The American Journal of Gastroenterology
Klaus R HerrlingerEduard F Stange

Abstract

Interleukin-11 has shown benefit in animal inflammatory bowel disease models. Recently, recombinant human interleukin-11 (rhIL-11) has been observed to induce remission in a subset of patients with mild to moderate Crohn's disease (CD). The present study compared the efficacy of rhIL-11 versus prednisolone in remission induction in CD. Patients with active CD were randomly assigned to receive either subcutaneous rhIL-11 (1 mg once weekly) and prednisolone placebo tablets, or active prednisolone (60 mg/day) and rhIL-11 placebo, for 12 weeks. Prednisolone/placebo was tapered after week 1, and patients were assessed every second week. Fifty-one patients received medication: 13/27 (rhIL-11) and 17/24 (prednisolone) completed 12 weeks of treatment. Remission rates (intent to treat) for rhIL-11 versus prednisolone were 4% versus 46% at week 4 (p < 0.001) and 19% versus 50% at week 6 (p < 0.05). Response to treatment (deltaCDAI > 100) was seen in 19% (rhIL-11) versus 63% (prednisolone) after 4 weeks (p < 0.002) and 37% versus 63% after 6 weeks (p = 0.1). After 12 weeks of treatment, it was observed that 22% (rhIL-11) versus 21% (prednisolone) had remained in remission. Frequent side effects of rhIL-11 included fever (n = 3), rash (4),...Continue Reading

References

Dec 10, 1999·The Journal of Clinical Investigation·W L TrepicchioJ G Krueger
Apr 21, 2001·Gastroenterology·W J SandbornUNKNOWN CDP571 Crohn's Disease Study Group
Mar 6, 2002·Alimentary Pharmacology & Therapeutics·B E SandsUNKNOWN RHIL-11 Crohn's Study group
Jan 3, 2003·The New England Journal of Medicine·Subrata GhoshUNKNOWN Natalizumab Pan-European Study Group

❮ Previous
Next ❯

Citations

Nov 8, 2011·Immunotherapy·Clémentine Perrier, Paul Rutgeerts
Jul 31, 2008·World Journal of Gastroenterology : WJG·Fausto Sanchez-MunozJesus-K Yamamoto-Furusho
Feb 26, 2011·World Journal of Gastroenterology : WJG·Guillaume BouguenLaurent Peyrin-Biroulet
Aug 27, 2009·Biologics : Targets & Therapy·Matteo BosaniGabriele Bianchi Porro
May 8, 2014·World Journal of Gastroenterology : WJG·Virginia PascualConcepción Núñez
Jan 24, 2014·Expert Opinion on Biological Therapy·Klaus R HerrlingerKlaus Fellermann
Sep 15, 2010·Expert Opinion on Investigational Drugs·Mario CottoneSara Renna
Nov 4, 2006·Alimentary Pharmacology & Therapeutics·K R Herrlinger, D P Jewell
Jan 27, 2010·International Reviews of Immunology·Nilanjan GhoshSubhash C Mandal
Sep 5, 2015·Mediators of Inflammation·Luz María MedranoElena Urcelay
Oct 13, 2007·Expert Opinion on Pharmacotherapy·A R Bremner, R M Beattie
Apr 16, 2008·Expert Opinion on Therapeutic Targets·Arthur Kaser, Herbert Tilg
Mar 12, 2015·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Paul M NguyenMatthias Ernst
Apr 29, 2015·Immunotherapy·Tracy L Putoczki, Matthias Ernst
May 18, 2016·The Journal of Infectious Diseases·Galina ShepelkovaAlexander Apt
Jan 10, 2018·Frontiers in Immunology·Claudia A Nold-PetryCharles A Dinarello
Aug 8, 2018·International Journal of Molecular Sciences·Moses M KasembeliDavid J Tweardy
Aug 31, 2006·Clinical Rheumatology·Alan EbringerClyde Wilson
Jan 16, 2010·Annals of the New York Academy of Sciences·Steven KozlowskiRaymond P Donnelly
May 1, 2010·Journal of Cellular Physiology·Anna BellizziValeria Pietropaolo
Mar 3, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Brian HoangRobert A Edwards
Apr 23, 2014·Nature Reviews. Immunology·Markus F Neurath
Sep 24, 2014·Annals of Biomedical Engineering·Andrew J GlowackiSteven R Little
Jun 20, 2018·BMC Immunology·Milad Sabzevary-GhahfarokhiEhsan Razmara
Aug 31, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Vassilis ValatasGeorge Kolios
Jan 15, 2014·Expert Review of Clinical Immunology·Keil AuerDario Sorrentino
Apr 5, 2013·Veterinary Ophthalmology·Tara R RichardsJonathan LaMarre
Sep 10, 2014·Acta Crystallographica. Section D, Biological Crystallography·Tracy L PutoczkiMichael D W Griffin
Nov 4, 2015·World Journal of Gastroenterology : WJG·Gonzalo Jesús Gómez-GómezBegoña Casís
Jun 24, 2016·Cell Biochemistry and Biophysics·Eugene A PermyakovSergei E Permyakov
Apr 21, 2012·Journal of Gastroenterology and Hepatology·Trevor A Winter, Susan Y Quan
Mar 5, 2019·Alimentary Pharmacology & Therapeutics·Heather CattKeith Bodger
Feb 1, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Anniina T VirtanenOlli Silvennoinen
Mar 18, 2020·Immunology·Carolyn A ThomsonAllan Mcl Mowat
Jul 3, 2021·Nature Reviews. Gastroenterology & Hepatology·Maria D GiraldezMatilde Bustos
Mar 8, 2011·The Journal of Allergy and Clinical Immunology·Mübeccel AkdisCezmi A Akdis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua zhong liu za zhi [Chinese journal of oncology]
Da-tong ChuAi-lian Zhang
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
J K ZhuX G Zhang
© 2022 Meta ULC. All rights reserved